Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance
Authors
Keywords
-
Journal
JOURNAL OF PATHOLOGY
Volume 237, Issue 3, Pages 363-378
Publisher
Wiley
Online
2015-07-15
DOI
10.1002/path.4583
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emerging Strategies for Treating Brain Metastases from Breast Cancer
- (2015) David P. Kodack et al. CANCER CELL
- Cell cycle control as a promising target in melanoma
- (2015) Belinda Lee et al. CURRENT OPINION IN ONCOLOGY
- Quantitative HER2 and p95HER2 levels in primary breast cancers and matched brain metastases
- (2015) R. Duchnowska et al. NEURO-ONCOLOGY
- Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines
- (2015) Majid Momeny et al. Oncotarget
- The localization of HER4 intracellular domain and expression of its alternately-spliced isoforms have prognostic significance in ER+ HER2- breast cancer
- (2015) Saori Fujiwara et al. Oncotarget
- Nuclear HER4 mediates acquired resistance to trastuzumab and is associated with poor outcome in HER2 positive breast cancer
- (2015) Siti Norasikin Mohd Nafi et al. Oncotarget
- Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA
- (2014) S. M. Swain et al. ANNALS OF ONCOLOGY
- Serpins Promote Cancer Cell Survival and Vascular Co-Option in Brain Metastasis
- (2014) Manuel Valiente et al. CELL
- Therapeutic Targeting of Cancers with Loss of PTEN Function
- (2014) Lloye Dillon et al. CURRENT DRUG TARGETS
- Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases: American Society of Clinical Oncology Clinical Practice Guideline
- (2014) Naren Ramakrishna et al. JOURNAL OF CLINICAL ONCOLOGY
- DNA Double-Strand Break Repair Genes and Oxidative Damage in Brain Metastasis of Breast Cancer
- (2014) Stephan Woditschka et al. JNCI-Journal of the National Cancer Institute
- Convergent and Divergent Cellular Responses by ErbB4 Isoforms in Mammary Epithelial Cells
- (2014) Vikram B. Wali et al. MOLECULAR CANCER RESEARCH
- Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S
- (2014) Lisa Sevenich et al. NATURE CELL BIOLOGY
- The maintenance of chromosome structure: positioning and functioning of SMC complexes
- (2014) Kristian Jeppsson et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Human breast cancer metastases to the brain display GABAergic properties in the neural niche
- (2014) J. Neman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ERBB3 is required for metastasis formation of melanoma cells
- (2014) S Tiwary et al. Oncogenesis
- Targeting MET Amplification as a New Oncogenic Driver
- (2014) Hisato Kawakami et al. Cancers
- Frequent Genetic Alterations in EGFR- and HER2-Driven Pathways in Breast Cancer Brain Metastases
- (2013) Ina Hohensee et al. AMERICAN JOURNAL OF PATHOLOGY
- Pazopanib Inhibits the Activation of PDGFRβ-Expressing Astrocytes in the Brain Metastatic Microenvironment of Breast Cancer Cells
- (2013) Brunilde Gril et al. AMERICAN JOURNAL OF PATHOLOGY
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- The prognostic value of Her4 receptor isoform expression in triple-negative and Her2 positive breast cancer patients
- (2013) Anna Machleidt et al. BMC CANCER
- Estrogen receptor α is the major driving factor for growth in tamoxifen-resistant breast cancer and supported by HER/ERK signaling
- (2013) Susan Thrane et al. BREAST CANCER RESEARCH AND TREATMENT
- Src Family Kinases as Novel Therapeutic Targets to Treat Breast Cancer Brain Metastases
- (2013) S. Zhang et al. CANCER RESEARCH
- Co-evolution of breast-to-brain metastasis and neural progenitor cells
- (2013) Josh Neman et al. CLINICAL & EXPERIMENTAL METASTASIS
- CNS Metastases in Breast Cancer: Old Challenge, New Frontiers
- (2013) N. U. Lin et al. CLINICAL CANCER RESEARCH
- Molecular Imaging of Death Receptor 5 Occupancy and Saturation Kinetics In Vivo by Humanized Monoclonal Antibody CS-1008
- (2013) I. J. G. Burvenich et al. CLINICAL CANCER RESEARCH
- Carcinoma cells misuse the host tissue damage response to invade the brain
- (2013) Han-Ning Chuang et al. GLIA
- ErbB3 downregulation enhances luminal breast tumor response to antiestrogens
- (2013) Meghan M. Morrison et al. JOURNAL OF CLINICAL INVESTIGATION
- 64Cu-DOTA-Trastuzumab PET Imaging in Patients with HER2-Positive Breast Cancer
- (2013) K. Tamura et al. JOURNAL OF NUCLEAR MEDICINE
- Functional Imaging of Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Using 64Cu-DOTA-Trastuzumab PET
- (2013) J. E. Mortimer et al. JOURNAL OF NUCLEAR MEDICINE
- Massively-parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary
- (2013) Richard W Tothill et al. JOURNAL OF PATHOLOGY
- Metastatic progression of breast cancer: insights from 50 years of autopsies
- (2013) Margaret C Cummings et al. JOURNAL OF PATHOLOGY
- Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study
- (2013) Sandra M Swain et al. LANCET ONCOLOGY
- MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study
- (2013) Paolo A Ascierto et al. LANCET ONCOLOGY
- HER4 and its cytoplasmic isoforms are associated with progression-free survival of malignant melanoma
- (2013) Trine O. Nielsen et al. MELANOMA RESEARCH
- Reply to ‘Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance’
- (2013) Hee Jin Lee et al. MODERN PATHOLOGY
- Letter to the editor regarding ‘Seol H, Lee HJ, Choi Y, et al. Intratumoural heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance’
- (2013) Martin C Chang MODERN PATHOLOGY
- erbB3 Is an Active Tyrosine Kinase Capable of Homo- and Heterointeractions
- (2013) M. P. Steinkamp et al. MOLECULAR AND CELLULAR BIOLOGY
- Mutational heterogeneity in cancer and the search for new cancer-associated genes
- (2013) Michael S. Lawrence et al. NATURE
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- IntOGen-mutations identifies cancer drivers across tumor types
- (2013) Abel Gonzalez-Perez et al. NATURE METHODS
- Implementing personalized cancer genomics in clinical trials
- (2013) Richard Simon et al. NATURE REVIEWS DRUG DISCOVERY
- Somatic Point Mutation Calling in Low Cellularity Tumors
- (2013) Karin S. Kassahn et al. PLoS One
- The Small GTPase ARF6 Stimulates -Catenin Transcriptional Activity During WNT5A-Mediated Melanoma Invasion and Metastasis
- (2013) A. H. Grossmann et al. Science Signaling
- Blocking NRG1 and Other Ligand-Mediated Her4 Signaling Enhances the Magnitude and Duration of the Chemotherapeutic Response of Non-Small Cell Lung Cancer
- (2013) G. V. Hegde et al. Science Translational Medicine
- Deciphering Signatures of Mutational Processes Operative in Human Cancer
- (2013) Ludmil B. Alexandrov et al. Cell Reports
- Incidence and time trends of brain metastases admissions among breast cancer patients in Sweden
- (2012) G Frisk et al. BRITISH JOURNAL OF CANCER
- Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network
- (2012) Nancy U. Lin et al. CANCER
- Combination of a MEK inhibitor at sub-MTD with a PI3K/mTOR inhibitor significantly suppresses growth of lung adenocarcinoma tumors in KrasG12D-LSL mice
- (2012) Brett H. Simmons et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Dual Targeting of EGFR and HER3 with MEHD7945A Overcomes Acquired Resistance to EGFR Inhibitors and Radiation
- (2012) S. Huang et al. CANCER RESEARCH
- PIK3CA Mutation H1047R Is Associated with Response to PI3K/AKT/mTOR Signaling Pathway Inhibitors in Early-Phase Clinical Trials
- (2012) F. Janku et al. CANCER RESEARCH
- Mutational Processes Molding the Genomes of 21 Breast Cancers
- (2012) Serena Nik-Zainal et al. CELL
- A Landscape of Driver Mutations in Melanoma
- (2012) Eran Hodis et al. CELL
- Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
- (2012) Marcin Imielinski et al. CELL
- Androgen-independent prostate cancer cells circumvent EGFR inhibition by overexpression of alternative HER receptors and ligands
- (2012) DOLORS CARRIÓN-SALIP et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study
- (2012) Pasi A Jänne et al. LANCET ONCOLOGY
- Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study
- (2012) Thomas Bachelot et al. LANCET ONCOLOGY
- Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance
- (2012) Hyesil Seol et al. MODERN PATHOLOGY
- The landscape of cancer genes and mutational processes in breast cancer
- (2012) Philip J. Stephens et al. NATURE
- Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
- (2012) Andrew V. Biankin et al. NATURE
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- qpure: A Tool to Estimate Tumor Cellularity from Genome-Wide Single-Nucleotide Polymorphism Profiles
- (2012) Sarah Song et al. PLoS One
- Burden of breast cancer with brain metastasis: a French national hospital database analysis
- (2012) L. Benjamin et al. JOURNAL OF MEDICAL ECONOMICS
- Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse
- (2011) J. Chuck Harrell et al. BREAST CANCER RESEARCH AND TREATMENT
- High frequency of complex TP53 mutations in CNS metastases from breast cancer
- (2011) C Lo Nigro et al. BRITISH JOURNAL OF CANCER
- Whole genome sequencing of matched primary and metastatic acral melanomas
- (2011) S. Turajlic et al. GENOME RESEARCH
- Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study
- (2011) Karen A Gelmon et al. LANCET ONCOLOGY
- A framework for variation discovery and genotyping using next-generation DNA sequencing data
- (2011) Mark A DePristo et al. NATURE GENETICS
- Neurosurgical management of metastases in the central nervous system
- (2011) Elizabeth B. Claus Nature Reviews Clinical Oncology
- Lapatinib Distribution in HER2 Overexpressing Experimental Brain Metastases of Breast Cancer
- (2011) Kunal S. Taskar et al. PHARMACEUTICAL RESEARCH
- Treatment of Brain Metastases: Chemotherapy
- (2011) Sean A. Grimm Current Oncology Reports
- Management of Brain Metastasis: Past Lessons, Modern Management, and Future Considerations
- (2011) Eugene Koay et al. Current Oncology Reports
- Epidemiology of Brain Metastases
- (2011) Lakshmi Nayak et al. Current Oncology Reports
- Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer
- (2010) E C Dijkers et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
- (2010) A. McKenna et al. GENOME RESEARCH
- The brain microenvironment and cancer metastasis
- (2010) Isaiah J. Fidler et al. MOLECULES AND CELLS
- Genome remodelling in a basal-like breast cancer metastasis and xenograft
- (2010) Li Ding et al. NATURE
- Distant metastasis occurs late during the genetic evolution of pancreatic cancer
- (2010) Shinichi Yachida et al. NATURE
- Resource Utilization in Patients with Brain Metastases Managed with Best Supportive Care, Radiotherapy and/or Surgical Resection: A Markov Analysis
- (2010) Carsten Nieder et al. ONCOLOGY
- The role of HER3, the unpretentious member of the HER family, in cancer biology and cancer therapeutics
- (2010) Dhara N. Amin et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads
- (2009) K. Ye et al. BIOINFORMATICS
- Fast and accurate short read alignment with Burrows-Wheeler transform
- (2009) H. Li et al. BIOINFORMATICS
- HER/ErbB receptor interactions and signaling patterns in human mammary epithelial cells
- (2009) Yi Zhang et al. BMC CELL BIOLOGY
- Brain Metastasis: Opportunities in Basic and Translational Research
- (2009) E. A. Maher et al. CANCER RESEARCH
- WNT/TCF Signaling through LEF1 and HOXB9 Mediates Lung Adenocarcinoma Metastasis
- (2009) Don X. Nguyen et al. CELL
- HER Family Receptor Abnormalities in Lung Cancer Brain Metastases and Corresponding Primary Tumors
- (2009) M. Sun et al. CLINICAL CANCER RESEARCH
- The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline
- (2009) Mark E. Linskey et al. JOURNAL OF NEURO-ONCOLOGY
- Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
- (2009) Sohrab P. Shah et al. NATURE
- Genes that mediate breast cancer metastasis to the brain
- (2009) Paula D. Bos et al. NATURE
- Real-time imaging reveals the single steps of brain metastasis formation
- (2009) Yvonne Kienast et al. NATURE MEDICINE
- Genome Alteration Print (GAP): a tool to visualize and mine complex cancer genomic profiles obtained by SNP arrays
- (2009) Tatiana Popova et al. GENOME BIOLOGY
- A Central Role for HER3 in HER2-Amplified Breast Cancer: Implications for Targeted Therapy
- (2008) S. T. Lee-Hoeflich et al. CANCER RESEARCH
- HER3 Is a Determinant for Poor Prognosis in Melanoma
- (2008) M. Reschke et al. CLINICAL CANCER RESEARCH
- Brain metastases: current management and new developments
- (2008) Riccardo Soffietti et al. CURRENT OPINION IN ONCOLOGY
- Heregulin-induced activation of ErbB3 by EGFR tyrosine kinase activity promotes tumor growth and metastasis in melanoma cells
- (2008) Yoko Ueno et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular Basis of Metastasis
- (2008) Anne C. Chiang et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More